中低收入国家宫颈癌放疗后阴道狭窄的范围综述
该范围综述汇总了24项来自9个中低收入国家的研究,评估宫颈癌放疗后阴道狭窄(RIVS)的发生率、评估方法与管理。可提取数据的研究中RIVS总体发生率中位数为48.8%(IQR 33.5-75.9),以RIVS为主要结局的研究报告发生率显著更高(P < .001),仅6项研究描述了管理策略,且无来自低收入国家的数据。
要点
- 中低收入国家宫颈癌放疗后RIVS总体发生率中位数为48.8%(IQR 33.5-75.9)。
- 以RIVS为主要结局的研究报告发生率显著更高(P < .001)。
- 仅6项研究描述管理策略,评估与报告不一致,无低收入国家数据。
核心结论
- RIVS在中低收入国家宫颈癌放疗患者中常见,但评估与报告不一致,管理实践描述不足。
研究设计与样本
- 纳入报告中低收入国家宫颈癌放疗患者RIVS的研究,共24项,代表9个中低收入国家,无低收入国家研究。
- 中位发表年份为2020年,半数研究为回顾性研究。
主要发现
- 可提取发生率数据的研究中,RIVS总体发生率中位数(IQR)为48.8%(33.5-75.9)。
- 以RIVS为主要结局的研究报告发生率显著高于非主要结局研究(P < .001)。
- 2014年后发表的研究发生率更高(P = .02)。
- 不同国家、地区或收入组之间未观察到显著差异。
- 仅6项研究描述了毒性管理策略。
关键数值与推荐
- RIVS总体发生率中位数(IQR)为48.8%(33.5-75.9)。
- 以RIVS为主要结局的研究发生率显著更高(P < .001)。
- 2014年后发表的研究发生率更高(P = .02)。
临床怎么用
- 在中低收入国家宫颈癌放疗随访中应重视RIVS的标准化评估与记录。
- 需结合文化背景制定干预措施以管理晚期阴道并发症。
- 管理策略报告有限,临床实践中应加强RIVS管理经验的总结与交流。
局限性
- 无来自低收入国家的数据。
- 标准化毒性评估使用有限,评估与报告不一致。
- 管理策略描述有限,仅6项研究涉及。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation-induced vaginal stenosis (RIVS) is a common late toxicity of cervical cancer radiation therapy, yet its incidence, assessment, and reporting in low- and middle-income countries (LMICs) are poorly characterized. This scoping review synthesizes existing evidence on the incidence, assessment methods, and management of RIVS in LMIC settings. METHODS AND MATERIALS: A scoping review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. PubMed, Scopus, and Web of Science were searched for available literature through December 2024 for studies reporting RIVS among women with cervical cancer treated with radiation therapy in LMICs. Data were extracted on study characteristics, incidence, assessment methods, and management. Nonparametric tests and Spearman correlations were used to explore associations between reported incidence and study-level variables. RESULTS: Twenty-four studies met the inclusion criteria, representing nine LMICs as defined by the World Bank; no studies originated from low-income countries. The median publication year was 2020, and half of the studies were retrospective. Among studies reporting extractable incidence data, the median (IQR) overall incidence of RIVS was 48.8% (33.5-75.9). Studies that identified RIVS as a primary outcome reported significantly higher incidence than those in which it was not a primary focus (P < .001). Incidence was also higher in studies published after 2014 (P = .02). No significant differences were observed across countries, regions, or income groups. Reporting of management strategies was limited, with only 6 studies describing toxicity management. CONCLUSIONS: RIVS is common among patients with cervical cancer treated in LMICs, yet assessment and reporting remain inconsistent, and management practices are poorly described. The absence of data from low-income countries and the limited use of standardized toxicity assessment hinder accurate estimation of survivorship burden. Improved documentation, standardized assessment, and culturally informed interventions are needed to address late vaginal morbidity in LMICs.
引用
- Myagmarsuren D, Alani A, Olatunji E, et al. Radiation-Induced Vaginal Stenosis in Patients With Cervical Cancer in Low- and Middle-Income Countries: A Scoping Review. Int J Radiat Oncol Biol Phys. 2026. PMID: 42167703. doi:10.1016/j.ijrobp.2026.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。